Aditya Bardia, MD, MPH, Director of Breast Cancer Research, Mass General Cancer Center, Attending Physician, Mass General Cancer Center, Associate Professor in Medicine, Harvard Medical School. In this video, he speaks about the Miami Breast 2022 discussion – Emerging Data on Oral Selective Estrogen Receptor Degraders and Other Novel Hormonal Therapies.
Podcast Aditya Bardia, MD @dradityabardia @MassGeneralNews #MiamiBreast22 #Breast22 Data on SERDs – Novel Hormonal Therapies
By Editor